Sign in
Not yet taking people in United StatesNo phase

Exoskeleton walking and spinal stimulation for bones after spinal cord injury

Tests spinal stimulation with exoskeleton walking in spinal cord injury.

Key facts

Who runs it
VA Office of Research and Development
Where
The Bronx and West Orange, United StatesSee the 2 sites
Trial code
Registry title
Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.
Status
Not yet recruiting
People taking part
24 people, planned
Started
1 Nov 2026
Expected to end
1 Nov 2032
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Exoskeleton-Assisted Walking (EAW)
  • Sham Transcutaneous Spinal Cord Stimulation (tSCS)
  • Active Transcutaneous Spinal Cord Stimulation (tSCS)
Record updated
22 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a long-standing, partial spinal cord injury who cannot walk and use a wheelchair all the time. It tests robot-suit (exoskeleton) walking with real or sham spinal cord stimulation through the skin.

Age
21 Years to 60 Years
Sex
All sexes can join.
Disease stage
Spinal cord injury more than 3 years ago, at level C5-T10, impairment grade C or D (partial injury). Leg motor score of 16 or more. Not able to walk, using a wheelchair 100% of the time. Able to grip crutches or a walker without help. Height between 62 inches and 74 inches, weight less than 220lbs (100 kg). Thigh length 14 to 19 in (36 to 48 cm), shank length 17 to 22 in (43 to 55 cm).
Earlier treatment
People currently in a gym or rehab program doing walking training such as exoskeleton walking cannot join. People currently taking medicines that affect muscle or bone cannot join.
Biomarker or test result
Bone scan (DXA): people with a hip T-score < -3.5 or knee bone density < 0.60 g/cm2 cannot join.

Main reasons for not taking part

  • Past fragility or injury fractures, unhealed fractures, or swelling, bruising or discoloration of the legs
  • Current bone disease, such as osteomyelitis or hyperparathyroidism
  • Pregnancy or plans to become pregnant during the study
  • Cannot safely have an MRI scan, including claustrophobia, a baclofen pump, or metal in the body such as a pacemaker
  • Very low bone density on the screening DXA scan

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Non-walkers with an SCI greater than 3 years post injury
  • As measured by a member of the study staff, participants who have a lower extremity motor score greater or equal to 16 on the INSCSCI exam with an impairment grade of C or D
  • Neurologic level of injury as determined by study staff between C5-T10 (completed at participant's screening)
  • Capable of gripping Lofstrand crutches and/or a walker without assistance
  • Wheelchair reliant 100% of the time
  • Height is between 62 inches and 74 inches
  • Weight less than 220lbs
  • Anthropometric compatibility with the EAW device:; Thigh length between 14 and 19 in (36 and 48 cm); Shank length between 17 and 22 in (43 and 55 cm)

Who cannot take part

  • Currently prescribed any medications that can affect muscle and/or bone metabolism, as determined by the study staff
  • As determined by the study physician from the screening health exam, a history of fragility or traumatic fractures, unhealed fractures, and signs of swelling, bruising, and discoloration of the legs
  • Current bone disease diagnosis (e.g., osteomyelitis, hyperparathyroidism)
  • Body metal, including any of the following:; metal fragments or pieces in eyes or any other part of body; pacemakers or other implanted electrical devices; aneurysm clips (metal clips on wall of a large artery); metallic prostheses (metal pins and heart valves); internal hearing aids (cochlear implants); permanent eyeliner; shrapnel fragments; piercing that cannot be removed
  • As determined by the study physician from the screening DXA study, a T-score at the total hip < -3.5 or aBMD of the knee (proximal tibia and/or distal femur) < 0.60 g/cm2 from the DXA screen
  • Positive pregnancy test at any of the study intervention or assessment visits, or if female participants plan to become pregnant over the course of the study, they will be excluded or withdrawn (if already enrolled) from participation
  • Currently in a gym/rehabilitation program performing ambulatory interventions such as EAW, as determined by the study staff
  • Medically unsafe to receive an MRI scan
  • Claustrophobia
  • Baclofen pump

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 60 years old?

Where in United States

  • James J. Peters VA Medical Center, Bronx, NYThe Bronx, United StatesContact: Robert JordanNot yet recruiting
  • Kessler FoundationWest Orange, United StatesContact: Gail F Forrest, PhDNot yet recruiting

About the trial

What the trial wants to find out

Immobilization following spinal cord injury (SCI) results in muscle and bone loss below the level of injury, which ultimately predisposes to fracture at several sites throughout the legs and can lead to several medical complications that can devastate quality of life. There is a scarcity of research that has successfully implemented rehabilitation and/or exercise training interventions to preserve the musculoskeletal system during the acute phase SCI, or possibly reverse the muscle and bone loss that has already occurred in chronic SCI. This study will compare the effect of exoskeleton-assisted walking (EAW) training combined with transcutaneous spinal cord stimulation (tSCS) (EAW + active tSCS), to that of EAW + sham tSCS, on measures of muscle and bone health in a cohort of chronically injured motor incomplete SCI. A successful outcome would expand treatment options to improve musculoskeletal health over the lifetime.

The 2 groups in the trial

  • Exoskeleton-Assisted Walking (EAW) + active Transcutaneous Spinal Cord Stimulation (tSCS)Treatment being tested

    The EAW + active tSCS group will receive simultaneous lumbosacral tSCS while simultaneously performing EAW.

    Treatment: Exoskeleton-Assisted Walking (EAW) and Active Transcutaneous Spinal Cord Stimulation (tSCS)

  • Exoskeleton-assisted walking (EAW) + sham Transcutaneous Spinal Cord Stimulation (tSCS)Sham treatment, for comparison

    The EAW + sham tSCS group will receive simultaneous lumbosacral sham tSCS while simultaneously performing EAW. Participants in both groups will receive 60 minutes of EAW + sham tSCS overground training per session for a total of 108 sessions (3 X week for 36 weeks).

    Treatment: Exoskeleton-Assisted Walking (EAW) and Sham Transcutaneous Spinal Cord Stimulation (tSCS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength
Plain-language title
Exoskeleton walking and spinal stimulation for bones after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07418398, who can take part
Record updated
22 July 2026